GlassScriptPhysician profile
Sherman Chan
NPI 1811184047
$9,736.02
in general payments reported to CMS, 2019-2025
34 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,105 · 2020: $1,096 · 2021: $1,062 · 2022: $948 · 2023: $1,178 · 2024: $2,077 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,238 · Travel and Lodging: $1,201 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,238.35 |
| Travel and Lodging | $1,200.69 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,662.62 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $1,454.44 | 2019-2025 | General - Erectile Dysfunction, Varithena Administration Pack |
| Neotract INC. | $1,346.36 | 2019-2020 | |
| Medtronic USA, INC. | $586.82 | 2019-2020 | |
| Coloplast Corp | $478.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $221.60 | 2022-2025 | |
| Urogen Pharma, INC. | $202.13 | 2022-2023 | Jelmyto |
| Astellas Pharma US INC | $174.33 | 2022-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $161.09 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $159.82 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $153.38 | 2022-2025 | Erleada |
| Myovant Sciences INC. | $149.60 | 2021-2022 | |
| Medtronic, INC. | $142.65 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $127.22 | 2020-2024 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $127.21 | 2021-2023 | Prolaris |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $108.35 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $56.08 | 2023-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $42.99 | 2019-2021 | |
| Pfizer INC. | $39.11 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $37.96 | 2022 | |
| Clarus Therapeutics INC. | $36.93 | 2021 | |
| Palette Life Sciences, INC. | $29.54 | 2022 | |
| Abbott Laboratories | $26.23 | 2021 | |
| Antares Pharma, INC. | $23.42 | 2020 | |
| Acerus Pharmaceuticals Corporation | $22.53 | 2021 | |
| Allergan, INC. | $21.67 | 2020 | |
| Foundation Medicine, INC. | $20.04 | 2021 | |
| Abc Home Medical Supply, INC. | $18.72 | 2022 | |
| Dentsply Ih INC. | $18.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.44 | 2022 | |
| Baxter Healthcare | $18.08 | 2019 | |
| Civco Medical Instruments | $17.50 | 2025 | |
| Travere Therapeutics, INC. | $16.37 | 2019 | |
| Tolmar, INC. | $15.36 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherman Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.